What do we want? ... 2591 news
when do we want it? ... NOW!
... over and over and ... [you know the story]
The value of this company is now in 2591. Although Daybue is a brilliant medical success, the market is treating it as a millstone around the neck.
Could be a pretty rough SP journey over the next couple of years, until the PMS P3 result comes in. Luckily, Daybue has ensured we have the financial independence to secure that. I consider a fair value takeover before then to now be a forlorn hope, as the rapidly reducing market cap will see to that.
Ann: Trofinetide marketing application submitted in Europe, page-24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
0.000(0.00%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.48 | $16.77 | $16.28 | $3.108M | 188.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105 | $16.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.54 | 885 | 2 |
View Market Depth
| Last trade - 16.13pm 28/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |